Evidence map›Paper›PMID 42312491›Full record

ArticleNucleic acids research2026

scParadise: tunable, highly accurate multi-level cell type annotation, unknown cell type identification, and modality imputation.

Elizaveta Chechekhina, Liya Shcherbakova, Maksim Vigovskiy, Amir Tukhvatulin, Denis Logunov, Dmitry Tychinin, Dmitry Svetlichnyy, Konstantin Kulebyakin, Vsevolod Tkachuk, Vadim Chechekhin

Abstract read
In one paragraph

Article in Nucleic acids research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Elizaveta ChechekhinaMedical Research and Educational Institute, Lomonosov Moscow State University, 27-1 Lomonosovsky Prospekt, 119192Moscow, Russia.ORCID 0000-0002-5377-2712
Liya ShcherbakovaMedical Research and Educational Institute, Lomonosov Moscow State University, 27-1 Lomonosovsky Prospekt, 119192Moscow, Russia.ORCID 0000-0003-2681-4777
Maksim VigovskiyMedical Research and Educational Institute, Lomonosov Moscow State University, 27-1 Lomonosovsky Prospekt, 119192Moscow, Russia.
Amir TukhvatulinFederal State Budget Institution "National Research Centre for Epidemiology and Microbiology named after Honorary Academician N F Gamaleya" of the Ministry of Health of the Russian Federation, 18 Gamaleya Street, 123098Moscow, Russia.ORCID 0000-0001-8506-2339
Denis LogunovFederal State Budget Institution "National Research Centre for Epidemiology and Microbiology named after Honorary Academician N F Gamaleya" of the Ministry of Health of the Russian Federation, 18 Gamaleya Street, 123098Moscow, Russia.
Dmitry TychininFederal State Budget Institution "National Research Centre for Epidemiology and Microbiology named after Honorary Academician N F Gamaleya" of the Ministry of Health of the Russian Federation, 18 Gamaleya Street, 123098Moscow, Russia.
Dmitry SvetlichnyyFederal State Budgetary Institution "Centre for Strategic Planning and Management of Biomedical Health Risks" of the Federal Medical Biological Agency (Centre for Strategic Planning of the FMBA of Russia), 10-1 Pogodinskaya Street, 119121Moscow, Russia.ORCID 0000-0002-3776-9871
Konstantin KulebyakinMedical Research and Educational Institute, Lomonosov Moscow State University, 27-1 Lomonosovsky Prospekt, 119192Moscow, Russia.ORCID 0000-0001-6954-5787
Vsevolod TkachukMedical Research and Educational Institute, Lomonosov Moscow State University, 27-1 Lomonosovsky Prospekt, 119192Moscow, Russia.
Vadim ChechekhinMedical Research and Educational Institute, Lomonosov Moscow State University, 27-1 Lomonosovsky Prospekt, 119192Moscow, Russia.ORCID 0000-0001-8489-9954

Funding

Russian Science Foundation 25-75-30005
6 · The paper itself

Abstract

In single-cell biology, the main limitation has shifted from data generation to converting sparse, heterogeneous single-cell RNA sequencing (scRNA-seq) datasets into accurate cell types, interpretable multi-omic states, and reproducible conclusions. To address these challenges, we present scParadise, which transforms scRNA-seq data to a new scientific knowledge. scParadise comprises three integrated tools: scAdam, a multi-level cell type annotation tool with unknown cell type identification; scEve, a cross-tissue modality imputation tool; and scNoah, a standardized benchmarking tool. Using scParadise, we corrected annotation mistakes in the Tabula Muris Senis atlas, showing that cells labeled as granulocytes are exclusively neutrophils and that presumably annotated macrophages actually represent a range of different cell types. Moreover, we identify three previously unknown natural killer T (NKT) cell subsets by imputing protein expression across tissues, which include CD56dim CD3+, CD56dim CD3+ CD4+, and CD56dim CD3+ CD8+ cell subsets in human visceral adipose tissue, which we verify by flow cytometry. These new subsets engage in obesity-related tumor necrosis factor-centric crosstalk with myeloid and adipose progenitors, thereby illuminating a new paradigm for immune-stromal interactions that contribute to chronic inflammation and impaired adipogenesis.

Indexed as

Single-Cell Gene Expression AnalysisSoftwareAnimalsHumansMacrophagesMolecular Sequence AnnotationNeutrophils

Identifiers

PMID42312491
PMCPMC13276494

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.